SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-24-024771
Filing Date
2024-03-21
Accepted
2024-03-21 16:18:41
Documents
14
Period of Report
2024-03-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0202300-8ka1_bio.htm   iXBRL 8-K/A 40562
  Complete submission text file 0001213900-24-024771.txt   261115

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phge-20240320.xsd EX-101.SCH 3919
3 XBRL DEFINITION FILE phge-20240320_def.xml EX-101.DEF 26852
4 XBRL LABEL FILE phge-20240320_lab.xml EX-101.LAB 37192
5 XBRL PRESENTATION FILE phge-20240320_pre.xml EX-101.PRE 25476
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0202300-8ka1_bio_htm.xml XML 6134
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38762 | Film No.: 24771621
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)